TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/18/21 17:00 | 5/14/21 | HTBX | Heat Biologics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Prendergast John K A | NC | D | S | -205 | 5.87 | 0 | -35 | -15 | 203 | D | |||||||||||||||
8/15/08 13:21 | 8/13/08 | AVGN | Avigen Inc de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Prendergast John K A | CA | D | S.m | -26 | 3.42 | 0 | -8 | -16 | 39 | D | |||||||||||||||
3/22/07 17:55 | 3/21/07 | AVGN | Avigen Inc de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Prendergast John K A | CA | D | S.m | -79 | 6.61 | 0 | -12 | -20 | 47 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |